Pharma's Almanac

199 Articles Available

0 9

Pediatric Clinical Trials

Pediatric Clinical Trials: Considerations for Enrollment and Retention

PAO-02-24-CL-04

Digital Pathology

Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform

PAO-01-24-CL-2

Recombinant Antibody

Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma

PAO-01-24-CL-4

Sustainable Clinical Trials

Driving a Sustainable Future in Clinical Trials through Decentralized Trial Models

PAO-12-23-CL-05

Decentralized Clinical Trials

Innovating DCTs Through Application and Cross-Functional Delivery

PAO-07-23-CL-02

Preclinical Data

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

PAO-05-23-CL-03

Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

PR-M03-23-03

Artificial Intelligence in Antibody Design

Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence

PAO-11-022-CL-15

Recombinant Proteins

The Expanding Role for Recombinant Proteins in Research

PAO-11-22-PATV-01

Asia-Pacific DCTs

Interest in Decentralized Trials Rising in Asia-Pacific

PAO-11-022-CL-10

Decentralized Clinical Trial Design

Reducing the Challenges Sites Face when Implementing Decentralized Trials

PAO-11-022-CL-05

European DCTs

Exploring Challenges and Considerations for Operationalizing DCTs in the European Union

PAO-09-022-CL-07

CRO

Crafting a Successful Partnership with a Contract Research Organization

PAO-06-022-CL-05

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

PAO-02-022-CL-14

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

PR-M03-22-05

Rare Disease Clinical Trials

Rare Disease Patients Benefit from Clinical Trial Flexibility

PAO-02-022-CL-03

Business Leadership

Former Surgeon General Jerome Adams Announced as Chairman of the Board of Total Diversity Clinical Trial Management

PR-M03-22-04

Investment

Focusing on the Potential of Midsized Pharma Service Organizations

PAO-03-22-R250-03

CRO

Accelerating Large Molecule Drug Development

PAO-02-22-R250-20

Private Equity

Supporting Growth for Middle-Market Companies

PAO-02-22-R250-22

Mergers and Acquisitions

Integrating Services Across the Full Spectrum of Cell and Gene Therapy

PAO-02-22-R250-10

CRO

Expanding a Full-Service CRO Offering into the United States

PAO-01-22-R250-01

M&A

Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene

PR-M01-22-09

Clinical Trials Logistics

Listening to Clients and Expanding Across the Clinical Supply Chain

PAO-10-21-CL-19

0 9

CRO